CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $927,000 | -94.7% | 51,600 | -91.3% | 0.14% | -88.6% |
| Q3 2018 | $17,415,000 | +2.7% | 592,959 | +59.0% | 1.22% | +2.7% |
| Q2 2018 | $16,960,000 | +48.7% | 372,988 | +72.7% | 1.18% | +31.3% |
| Q1 2018 | $11,406,000 | -4.6% | 216,024 | +22.9% | 0.90% | +16.9% |
| Q4 2017 | $11,957,000 | -32.8% | 175,842 | -18.6% | 0.77% | -33.5% |
| Q3 2017 | $17,795,000 | +153.8% | 215,962 | +188.4% | 1.16% | +142.0% |
| Q2 2017 | $7,011,000 | +270.2% | 74,881 | +263.5% | 0.48% | +426.4% |
| Q3 2015 | $1,894,000 | – | 20,600 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |